Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab
in adult patients of black race with systemic lupus erythematosus (SLE; lupus).